SCHEMBL1089641

SCHEMBL1089641

CN(C)CCNc1nc(N2CCCCCC2)c2ccccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.61
KMT2A Q03164 4/20 0.54
LMNA P02545 4/20 0.54
MAPT P10636 4/20 0.54
MEN1 O00255 3/20 0.54
HPGD P15428 2/20 0.54
HTT P42858 2/20 0.54
RECQL P46063 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
SPIN4 Q56A73 1/20 0.54
SPIN3 Q5JUX0 1/20 0.54
SPIN2B Q9BPZ2 1/20 0.54
SPIN1 Q9Y657 1/20 0.54
ALDH1A1 P00352 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX12 P18054 1/20 0.54
CYP2C19 P33261 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089644 1.00 MRGPRX1 (0.61) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1090089 1.00 MRGPRX1 (0.61) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1089104 0.99 MRGPRX1 (0.63) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1090582 0.93 MRGPRX1 (0.59) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1089882 0.93 MRGPRX1 (0.59) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1088747 0.93 MRGPRX1 (0.59) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1088763 0.92 MRGPRX1 (0.58) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1090567 0.92 MRGPRX1 (0.60) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1089154 0.88 MRGPRX1 (0.59) MRGPRX1KMT2ALMNAMAPTMEN1
SCHEMBL1089378 0.88 MRGPRX1 (0.59) MRGPRX1KMT2ALMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885KMT2A 3064/4885LMNA 3658/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885KMT2A 3064/4885LMNA 3658/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885KMT2A 3064/4885LMNA 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.